Cancer is one of the most fatal diseases of recent times that causes several deaths every
year. The disease variations in different parts of the world, the impact of available medical …

Background & Aims The aim of this study was to provide an overview of the burden of
esophageal cancer in 185 countries in 2020 and projections for the year 2040. Methods …

2021 年1 月, 国际癌症研究机构团队在美国癌症学会旗下权威杂志《 临床医师癌症杂志》(CA: A
Cancer Journal for Clinicians) 发表了最新的全球癌症统计报告. 该报告阐述了2020 年36 …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Background Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell
death 1 receptor. The combination of chemotherapy and immunotherapy may have …

Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients, yet harbours
mutation-derived T cell neoantigens that are suitable for vaccines,. Here in a phase I trial of …

Background Although colonoscopy is widely used as a screening test to detect colorectal
cancer, its effect on the risks of colorectal cancer and related death is unclear. Methods We …

Background Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients
with resectable non–small-cell lung cancer (NSCLC). Perioperative regimens may combine …

Objective Colorectal cancer (CRC) is the third most common cancer worldwide. The
geographical and temporal burden of this cancer provides insights into risk factor …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …